Breaking News, Financial News

Financial Report: Abbott 1Q

Worldwide pharmaceutical sales were $3.6 billion (-6%). Humira sales were $1.0 billion (+17%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 1Q 1Q Revenues: $6.7 billion (-1%) 1Q Earnings: $1.4 billion(+53%) Comments: Worldwide pharmaceutical sales were $3.6 billion (-6%). Humira sales were $1.0 billion (+17%). Kaletra sales dropped 17% to $292 million, while Depakote sales were down 65% to $129 million due to generic competition. TriCor/Trilipix sales were $253 million (+3%). Worldwide vascular sales were $645 million (+43%) with Coronary Stent sales up 112% to $402 million....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters